Cancer survivor Scott Collings has declared his boom gelding Mogo Magic is primed to bounce back to his best at Eagle Farm on ...

A collaborative study published on January 21 in Nature Communications presents a novel strategy to improve the effectiveness ...

A collaborative study, published on January 21 on Nature Communications, presents a novel strategy to improve the ...

CIRBP Family, Tumors, Molecular Mechanisms, RNA-Binding Proteins, Cellular Stress Share and Cite: Cai, Y. , Wang, T. and Zhan ...

Medical review of Phase 1 cohorts demonstrated no safety issuesData to be presented at the 10th Annual Innate Killer Summit, March 3-5 BOCA RATON, Fla, Feb. 12, 2025 (GLOBE NEWSWIRE) -- INmune Bio ...

INmune Bio Inc. (NASDAQ: INMB) (the "Company"), a clinical-stage immunology and inflammation company, continues to advance its Natural Killer (NK) cell therapy, INKmune™, in a Phase I/II trial (the ...

Medical experts through out di world dey wonder say cancer cases dey increase in younger pipo wey di disease no dey dia ...

Cancer Prevention Research publishes articles that focus on cancer prevention, preclinical, clinical, and translational research, with special attention given to molecular discoveries and an emphasis ...

Cantonese salted fish, possibly due to how it's prepared and how early some people start eating it, contributes to ...

Transferrin receptor 1 (TfR1) has been shown to be upregulated in nasopharyngeal carcinoma (NPC). Here the authors report that TfR1 can be targeted in hypoxic NPC lesions using ferritin nanozymes.

The leading Triple Negative Breast Cancer Companies such as Shanghai Henlius Biotech, Jiangsu HengRui Medicine Co., Ltd., G1 ...